0.3242
Schlusskurs vom Vortag:
$0.3151
Offen:
$0.315
24-Stunden-Volumen:
349.73K
Relative Volume:
0.62
Marktkapitalisierung:
$7.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0561
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
+4.58%
1M Leistung:
-0.34%
6M Leistung:
-51.47%
1J Leistung:
-72.76%
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Vergleichen Sie ADIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ADIL
Adial Pharmaceuticals Inc
|
0.3242 | 7.56M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
How Adial Pharmaceuticals Inc. stock benefits from strong dollarIndex Update & Weekly High Momentum Picks - Newser
Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN
Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn
Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews
Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus
Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com
Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative
Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - MarketScreener
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options data2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumStock Surge & Reliable Price Breakout Signals - newser.com
Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow - Finimize
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025Portfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Adial Pharmaceuticals (ADIL) Advances Towards FDA Approval with AD04 - GuruFocus
Adial Pharmaceuticals Q3 net loss beats expectations on lower R&D expenses - MarketScreener
Full technical analysis of Adial Pharmaceuticals Inc. stockPortfolio Gains Report & Proven Capital Preservation Methods - newser.com
[10-Q] ADIAL PHARMACEUTICALS, INC. Quarterly Earnings Report | ADIL SEC FilingForm 10-Q - Stock Titan
Real time social sentiment graph for Adial Pharmaceuticals Inc.Weekly Stock Summary & Consistent Growth Equity Picks - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):